434 related articles for article (PubMed ID: 29582237)
1. Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
Kolb JM; Flack KF; Chatterjee-Murphy P; Desai J; Wallentin LC; Ezekowitz M; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
Dig Dis Sci; 2018 Jul; 63(7):1878-1889. PubMed ID: 29582237
[TBL] [Abstract][Full Text] [Related]
2. Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.
Lee KH; Park HW; Lee N; Hyun DY; Won J; Oh SS; Park HJ; Kim Y; Cho JY; Kim MC; Sim DS; Yoon HJ; Yoon NS; Kim KH; Hong YJ; Kim JH; Ahn Y; Jeong MH; Park JC; Cho JG
Europace; 2017 Dec; 19(suppl_4):iv1-iv9. PubMed ID: 29220421
[TBL] [Abstract][Full Text] [Related]
3. Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
Flack KF; Desai J; Kolb JM; Chatterjee P; Wallentin LC; Ezekowitz M; Yusuf S; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
Clin Gastroenterol Hepatol; 2017 May; 15(5):682-690. PubMed ID: 27765728
[TBL] [Abstract][Full Text] [Related]
4. Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Kent AP; Pogue J; Spahr J; Clemens A; Noack H; Diener HC; Wallentin L; Yusuf S; Connolly SJ
Europace; 2016 Jul; 18(7):973-8. PubMed ID: 26944733
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care.
Gorst-Rasmussen A; Lip GY; Bjerregaard Larsen T
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1236-1244. PubMed ID: 27229855
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
Aisenberg J; Chatterjee-Murphy P; Friedman Flack K; Weitz JI; Ruff CT; Nordio F; Mercuri MF; Choi Y; Antman EM; Braunwald E; Giugliano RP
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003998. PubMed ID: 29748353
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
[TBL] [Abstract][Full Text] [Related]
9. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
Loffredo L; Perri L; Violi F
Dig Liver Dis; 2015 May; 47(5):429-31. PubMed ID: 25732432
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran use in elderly patients with atrial fibrillation.
Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
[TBL] [Abstract][Full Text] [Related]
11. Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.
Lau WCY; Li X; Wong ICK; Man KKC; Lip GYH; Leung WK; Siu CW; Chan EW
J Thromb Haemost; 2017 Oct; 15(10):1923-1933. PubMed ID: 28748652
[TBL] [Abstract][Full Text] [Related]
12. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
14. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
Xu WW; Hu SJ; Wu T
J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581
[TBL] [Abstract][Full Text] [Related]
15. Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation.
Stam-Slob MC; Connolly SJ; van der Graaf Y; van der Leeuw J; Dorresteijn JAN; Eikelboom JW; Peters RJG; Alings M; Visseren FLJ
Circulation; 2019 Jun; 139(25):2846-2856. PubMed ID: 31046423
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
17. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
Chevalier J; Giroud M; de Pouvourville G
Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
Clemens A; Strack A; Noack H; Konstantinides S; Brueckmann M; Lip GY
Ann Med; 2014 Dec; 46(8):672-8. PubMed ID: 25174259
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
Romanelli RJ; Nolting L; Dolginsky M; Kym E; Orrico KB
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):126-34. PubMed ID: 26812933
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
Nagarakanti R; Wallentin L; Noack H; Brueckmann M; Reilly P; Clemens A; Connolly SJ; Yusuf S; Ezekowitz MD
Am J Cardiol; 2015 Oct; 116(8):1204-9. PubMed ID: 26282726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
